Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
about
Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1Pancreatic regulation of glucose homeostasisEffects of GLP-1 on appetite and weightIndirect effects of glucagon-like peptide-1 receptor agonist exendin-4 on the peripheral circadian clocks in miceReversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese miceGut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutideNutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar ratsThe future role of gut hormones in the treatment of obesityThe TRPA1 agonist, methyl syringate suppresses food intake and gastric emptying.Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake.Obesity treatment: novel peripheral targets.The incretin system and cardiometabolic diseaseThe relevance of the glycaemic index to our understanding of dietary carbohydrates.Seventy-five gram glucose tolerance test to assess carbohydrate malabsorption and small bowel bacterial overgrowth.Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.Oral and gastrointestinal sensing of dietary fat and appetite regulation in humans: modification by diet and obesityProglucagon-derived peptides: mechanisms of action and therapeutic potential.Impaired enteroendocrine development in intestinal-specific Islet1 mouse mutants causes impaired glucose homeostasis.Emerging role of GLP-1 receptor agonists in the treatment of obesity.GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways.The vagus nerve, food intake and obesity.Effects of glucagon-like peptide 1 on glycemia control and its metabolic consequence after severe thermal injury--studies in an animal modelChanges in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery.Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction.Glucose sensing in L cells: a primary cell study.The role of incretins in glucose homeostasis and diabetes treatment.Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.The postprandial rise in plasma cortisol in men is mediated by macronutrient-specific stimulation of adrenal and extra-adrenal cortisol productionThe effect on glucagon, glucagon-like peptide-1, total and acyl-ghrelin of dietary fats ingested with and without potato.Glucagon-like peptide-1: a potent regulator of food intake in humans.Effect of macronutrient composition on short-term food intake and weight lossNa(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretionBariatric surgery for extreme adolescent obesity: indications, outcomes, and physiologic effects on the gut-brain axisGut peptides in the treatment of diabetes mellitus.Physiology of incretins in health and disease.Role of gastrointestinal hormones in feeding behavior and obesity treatment.Appetite regulation and weight control: the role of gut hormones.TRPM5 is critical for linoleic acid-induced CCK secretion from the enteroendocrine cell line, STC-1
P2860
Q26744254-DDC1B7BD-4020-4E9A-B840-6178ED2C652EQ26749211-A32D3BA5-F4AC-420C-BEAE-84AAE5828352Q26766485-B2408933-1B79-48F7-8A25-7D4FD53B9BF9Q27011627-025E0533-668C-4A53-A2BB-EE0E0BF9DA3BQ27301386-B5C22B67-6FDF-4076-8093-65D4F160BF28Q27316004-50BBAC62-2063-4F4E-9DEC-975820B25C2BQ28081671-92A2724C-7AF8-4B13-943E-048E11070482Q28564632-FC3225B9-FDA1-4422-953B-F72A87FDC032Q30357431-4A703525-FF70-4CC3-8D7D-0005DD79A17FQ31131497-BDCF2960-3449-4DBE-BF5E-87F98C6D8D79Q33593471-B2534FAB-DC5E-44FB-B00B-760A35C27685Q33607971-64DD6382-16CB-4D18-817A-53973E660787Q33776092-91196F7D-E565-41EA-AEAC-D592DE0C1585Q33953674-D386ECF1-FCEC-4D87-BC52-F377C8C11BF7Q34012977-75C0119C-2CA8-4C7D-AE66-34FE4FA829D2Q34120699-7E2A5899-54ED-4B09-8D82-C6223384DA0BQ34289440-7F652F47-3E1E-49E4-BB43-D06A039639E2Q34310033-4B72D3F7-B5A2-45F0-890E-1220DA431706Q34452524-9FFF29A9-6FBB-47F8-8583-9AEFBAC44948Q34519292-3E31F010-EEFB-4D3B-BF7E-1871B1EA170FQ34620465-81CB6632-4CE3-44AE-9AA3-83B858C2F60EQ34727731-F3FD8DBF-B5A5-438D-AAE8-05D91A495A8CQ34778864-5A089B79-3D69-48B3-8600-F7652076265DQ34810392-FB9174B1-07D8-4439-859E-455CE5A3CD6CQ34824270-380B6A85-EE1E-41E4-94BF-3E7A2FC3805FQ34890607-807FA7E0-8542-480D-A10A-31990F21B3DDQ34890796-E0E2A725-B126-4D35-BBD1-6BADCB4C2CEBQ34901533-440A6BE4-2495-4EBC-B23E-352508692A63Q35121793-8D9E1938-9956-4F85-8FEA-9FF436B919B6Q35358986-CCB1D742-7B34-4A13-8E39-5AC7D8C281AAQ35543158-2C6D2E23-7262-4319-A164-B2F72F986B0BQ35565562-F2EA3804-FA48-4772-9DDC-26558912AB7AQ35584652-7EE373DC-65EC-4186-AD20-46FF5A898666Q35612377-3D163053-4890-4E4E-8562-656DFADE5436Q35677192-99B1AD4F-4535-458A-98DC-481A406E8A62Q35688209-D8D22AF4-B2CF-4D81-B6E5-FFED58808014Q35760279-9B819B90-6451-421D-AF59-C03673ECB10BQ35766237-526821F0-AA42-4A2B-9B33-3C1347942967Q35825708-5162933C-1ECF-4AEC-B1D1-924E57F8FDD6Q35895745-5872E6C4-3C0F-4137-984D-47A223F89B21
P2860
Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Glucagon-like peptide-1 and gl ...... vels in response to nutrients.
@en
Glucagon-like peptide-1 and gl ...... vels in response to nutrients.
@nl
type
label
Glucagon-like peptide-1 and gl ...... vels in response to nutrients.
@en
Glucagon-like peptide-1 and gl ...... vels in response to nutrients.
@nl
prefLabel
Glucagon-like peptide-1 and gl ...... vels in response to nutrients.
@en
Glucagon-like peptide-1 and gl ...... vels in response to nutrients.
@nl
P2093
P356
P1433
P1476
Glucagon-like peptide-1 and gl ...... vels in response to nutrients.
@en
P2093
P304
P356
10.1159/000201231
P577
1995-01-01T00:00:00Z